American journal of hypertension · 2026
Hypertension Medication Changes in Patients Prescribed Remote Monitoring.
СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Winkler Calvin J, Petito Lucia C, Peprah Yaw, Lee Ji Young, Sato Hironori, Persell Stephen D
Аннотация
BACKGROUND: Remote patient monitoring (RPM) includes home blood pressure (BP) measurement with readings sent directly to the electronic health record (EHR). We hypothesize that RPM facilitates quicker, more frequent, more appropriate antihypertensive medication changes.
METHODS: Patients with hypertension in 6 primary care clinics were prescribed RPM between November 2020 and August 2021 (N = 288) and matched to 4 control patients (N = 1152). Office and RPM BP readings and medication data over 18 months were extracted from the EHR. RPM patients were classified as baseline-controlled (office and RPM <130/<80 mmHg), sustained (office and RPM ≥130 and/or ≥80), white-coat (office ≥130 and/or ≥80, RPM <130/<80), or masked hypertension (office <130/<80, RPM ≥130 and/or ≥80).
RESULTS: RPM patients had earlier first antihypertensive medication changes, with half of RPM patients having ≥1 change by 228 days versus 530 days for controls. RPM patients had more total medication changes, with 25% of RPM patients having ≥4 (median 1; 25th-75th percentiles 0-4) changes versus ≥2 (median 1; 0-2) changes in controls. Compared to baseline sustained hypertension RPM users, white-coat hypertension users were less likely to have ≥1 medication increase (24% [N = 11] versus 53% [N = 74], P = .001) within 12 months. Compared to baseline-controlled RPM users, masked hypertension users were less likely to have ≥1 medication decrease (0% [N = 0] versus 44% [N = 8]; P = .003) within 12 months.
CONCLUSIONS: Even without additional staff dedicated to medication adjustment, RPM facilitated quicker medication changes, more total changes, and differential prescribing decisions for white-coat and masked hypertension patients supporting RPM use in primary care.
CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov identifier: NCT05562921.
METHODS: Patients with hypertension in 6 primary care clinics were prescribed RPM between November 2020 and August 2021 (N = 288) and matched to 4 control patients (N = 1152). Office and RPM BP readings and medication data over 18 months were extracted from the EHR. RPM patients were classified as baseline-controlled (office and RPM <130/<80 mmHg), sustained (office and RPM ≥130 and/or ≥80), white-coat (office ≥130 and/or ≥80, RPM <130/<80), or masked hypertension (office <130/<80, RPM ≥130 and/or ≥80).
RESULTS: RPM patients had earlier first antihypertensive medication changes, with half of RPM patients having ≥1 change by 228 days versus 530 days for controls. RPM patients had more total medication changes, with 25% of RPM patients having ≥4 (median 1; 25th-75th percentiles 0-4) changes versus ≥2 (median 1; 0-2) changes in controls. Compared to baseline sustained hypertension RPM users, white-coat hypertension users were less likely to have ≥1 medication increase (24% [N = 11] versus 53% [N = 74], P = .001) within 12 months. Compared to baseline-controlled RPM users, masked hypertension users were less likely to have ≥1 medication decrease (0% [N = 0] versus 44% [N = 8]; P = .003) within 12 months.
CONCLUSIONS: Even without additional staff dedicated to medication adjustment, RPM facilitated quicker medication changes, more total changes, and differential prescribing decisions for white-coat and masked hypertension patients supporting RPM use in primary care.
CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov identifier: NCT05562921.